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A B S T R A C TObjectives: High hospitalization rates, prolonged length of stay, and
increased risks of subsequent events mean a steep increase in health
care usage after stroke. No study, however, has examined to what
extent increased costs after transient ischemic attack (TIA) or stroke
are due to hospitalizations for the initial event, recurrent events, and/
or nonvascular hospitalizations, and how costs compare with the year
prior to the event. Methods: We studied patients in a population-
based cohort study (Oxford Vascular Study) in the United Kingdom
from 2003 to 2007. Hospitalization and cost details were obtained from
patients’ individualized Hospital Episode Statistics records. Results:
A total of 295 incident TIA and 439 incident stroke patients were
included. For patients with stroke, average costs increased from £1437
in the year pre-event to £6629 in the year post-event (Po 0.0001).
Sixty-four percent (£4224) of poststroke costs were due to hospitaliza-
tions linked to the index stroke, more than 30% of which were given
nonvascular primary diagnoses on Hospital Episode Statistics, andsee front matter Copyright & 2013, International
r Inc.
.1016/j.jval.2012.10.013
hwell@clneuro.ox.ac.uk.
ndence to: Peter M. Rothwell, Stroke Prevention Re
Radcliffe Hospital, Oxford OX3 9DU, UK£653 (10%) were due to hospitalizations linked to subsequent vascular
events. For patients with TIA, costs increased from £876 1 year before
the event to £2410 in the year post-event (P o 0.0001). Patients with
TIA incurred nonsignificantly higher costs due to hospitalizations
linked to subsequent vascular events (£774) than for hospitalizations
linked to the index TIA (£720). Conclusions: Hospital costs increased
after TIA or stroke, primarily because of increased initial cerebrovas-
cular hospitalizations. The finding that costs due to nonvascular
diagnoses also increased after TIA or stroke appears, in part, to be
explained by the miscoding of TIA/stroke-related hospitalizations in
electronic information systems.
Keywords: cost analysis, health care utilization, regression modeling,
stroke.
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Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
High hospitalization rates, prolonged length of stay and rehabi-
litation, and an increased risk of subsequent vascular events
mean a steep increase in the use of health care resources and
costs after stroke and to a lesser extent after transient ischemic
attack (TIA) [1–4]. In addition, there is evidence that patients with
stroke are at an increased risk of infection [5], falling [6], and
experiencing bone fractures [7], with a further increased like-
lihood of higher hospital use and costs.
As TIA and stroke are associated with old age and generally
occur in patients with other comorbidities [8], such patients are
likely to consume substantial hospital resources even if they had
not suffered a TIA or stroke, making the impact of disease on
costs difficult to determine. Despite this, evidence from a litera-
ture review showed that only a minority of studies assessed the
costs that could be directly attributed to TIA or stroke by either
comparing costs of patients with controls or comparing costs
incurred before the event to subsequent costs [9], with none
including patients with TIA [9]. In addition, no study examined
the reasons for the observed increase in costs after stroke, that is,
whether observed increases in costs were due to hospitalizationsfor the initial event, recurrent events, and/or noncerebrovascular
causes.
The objective of this study, therefore, was to compare differ-
ences in hospitalization resource use and costs during the 12
months before and after TIA or stroke onset and to investigate
the reasons for any observed differences between the two time
periods.Methods
The Oxford Vascular Study
The Oxford Vascular Study (OXVASC) population comprises more
than 91,000 patients registered in nine general practices across
Oxfordshire, UK. The study methods have been described else-
where [8]. Briefly, patient registration began on April 2002 and is
ongoing. Only consenting patients recruited from April 1, 2003, to
March 31, 2007, were included in this analysis. Patients recruited
between April 1, 2002, and March 31, 2003, were excluded as
electronic Hospital Episode Statistics (HES) records for the year
before the event were not obtained. Patients in whom TIA orSociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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lapping methods of ‘‘hot’’ and ‘‘cold’’ pursuit and considered for
inclusion [10], including the following:1) A daily (weekdays only), urgent open-access ‘‘TIA clinic’’ to
which participating general practitioners and the local acci-
dent and emergency department send all individuals with
suspected TIA or stroke whom they would not normally admit
to hospital, with alternative on-call review provision at
weekends;2) Daily searches of admissions to the medical, stroke, neurol-
ogy, and other relevant wards;3) Daily searches of the local accident and emergency depart-
ment attendance register;4) Monthly computerized searches of general practitioner diag-
nostic coding and hospital discharge codes;5) Monthly searches of all cranial and carotid imaging studies
performed in local hospitals; and6) Monthly reviews of all death certificates and coroners reports.
Patients with suspected TIA/stroke were assessed urgently by
a study clinician. Stroke was defined according to World Health
Organization definitions and included all ischemic events, intra-
cerebral hemorrhage, subarachnoid hemorrhage, and strokes of
uncertain type. Informed consent was sought, and assessments
of neurological impairment, history of presentation, medical and
social history, and risk factors were performed. Impairment was
measured by using the National Institutes of Health Stroke Scale
(NIHSS), which was used to categorize event severity. Minor
events were defined as NIHSS scores of less than or equal to 3,
moderate as scores from 4 to 10, and severe as scores of more
than 10.
To better understand the impact of stroke and TIA on hospital
resource use and costs, we excluded from the analyses all those
patients with a history of stroke and TIA. Surviving patients were
then followed-up face to face by a research nurse at 1, 6, 12, 24, and
60 months after the event. Patients were also followed-up via their
general practitioner records, recurrent vascular events were identified
by ongoing ascertainment, and all patients had mortality follow-up.
Resource use
Resource use for each patient was obtained from the date of first
TIA or stroke within the OXVASC period (i.e., index event) until 1-
year follow-up or death within that period. In addition, the
resources consumed within the 12 months prior to the index
event were obtained. Details of hospital admissions were
obtained from the patient’s HES records [11]. HES contain details
of all admissions to English hospitals funded by the National
Health Service (NHS). For each hospital admission, HES provided
information on the primary diagnosis and secondary diagnoses
(coded using The International Statistical Classification of Diseases
and Related Health Problems, 10th Revision [ICD-10]), date of admis-
sion and discharge, admission method, and details about the
procedures and operations undertaken during each admission
(coded by using the Tabular List of the Classification of Surgical
Operations and Procedures).
For hospitalizations in which the patient was admitted and
discharged on the same day, the number of days in hospital was 0
and the hospitalization was classified as a day case. When the
index event occurred while in hospital, the hospital days before the
event and those on or after the event were treated as pre- and
postevent days, respectively. For those hospitalizations in which the
patient was admitted during the 1-year study period after the index
event, but discharged more than 1 year after event onset, we took
into account only the days in hospital occurring during the 1-year
period.Reasons for hospitalization were determined by examining
the primary diagnosis codes. For the purpose of our analysis,
cerebrovascular hospitalizations were those with an ICD-10 pri-
mary diagnosis code of G450 to G648, H340 to H342, H348, or I600
to I698; cardiovascular were those with ICD-10 codes of I00 to
I528, or I700 to I99; and those hospitalizations with any other ICD-
10 primary diagnosis code were recorded as nonvascular. As
hospitalizations could have more than one primary diagnosis
(e.g., an admission diagnosis and a discharge diagnosis), hospi-
talizations with multiple primary diagnoses in which at least one
was for cerebrovascular disease were coded as cerebrovascular,
irrespective of other primary diagnoses.
Hospitalizations occurring within 7 days of the index event
(including those in which the index event occurred while in
hospital), irrespective of primary diagnosis, were linked to that
event. In addition, if the patient was subsequently discharged to
another hospital, that hospitalization was also linked to the
event (e.g., patient was transferred from the acute hospital to a
community hospital). By using the same methodology, we also
linked hospitalization information with subsequent vascular
events, including stroke, TIA, and coronary and peripheral
vascular disease events. Subsequent vascular events were identi-
fied by face-to-face follow-up and as part of the ongoing OXVASC
ascertainment process. However, for those patients already
hospitalized when a subsequent vascular event occurred, it was
not possible to separately attribute resources to the multiple
events and so all the days in hospital were combined together as
part of the initial event.
Unit costs
In England, NHS hospitals are reimbursed for the services they
provide through a national tariff of prices reflecting the national
average cost of providing a hospital service. Each hospital service
is assigned to a Health Resource Group (HRG) that groups
together similar clinical procedures that cost an equivalent
amount to deliver [12]. Prices in the national tariff have been
set on the basis of the average cost of providing a particular HRG
by using data gathered from NHS hospitals. In addition, hospitals
receive additional funding for high-cost drugs, additional hospi-
talization days past a certain threshold, and provision of direct-
access diagnostics and specialized rehabilitation.
Each hospitalization was valued by using the 2008/09 HRG
English tariff. To determine the HRG for each hospitalization, and
any additional payments received for the provision of additional
services, each hospitalization in HES was coded by using the HRG
grouper (version 4 2008/09) software (The Health and Social Care
Information Centre, Leeds, UK). HRGs were then linked to a series
of elective and emergency reference costs obtained from the
2008/09 schedule of NHS reference costs [13].
Statistical analyses
Hospitalizations were reported as rates (i.e., the total number of
hospitalizations divided by the total time of observation). Rates
before and after the event were reported with their standard error
and compared by using rate ratios reported alongside 95%
confidence intervals (CIs). Statistical differences were evaluated
assuming a Poisson distribution. Days in hospital and costs were
reported as means together with their SD, with mean differences
between the two time periods reported alongside 95% CIs, and
evaluated by using a Student’s two-sided t test. Hospital days and
costs for patients dying after the index event were analyzed in
the same way as for survivors.
To assess the predictors of costs during the year after the
index event, a two-part regression model was used. A logistic
regression was first used to assess the predictors of having at
least one hospital admission during the year following the index
Table 1 – Baseline and event characteristics for TIA and
stroke patients.
Stroke
(n ¼ 439)
TIA
(n ¼ 295)
Age (y), mean  SD 74  13 71  14
Males 225 (51) 126 (43)
Previous disability 82 (19) 32 (11)
Previous MI 46 (11) 23 (8)
Previous angina 57 (13) 34 (12)
Hypertension 246 (57) 136 (46)
Diabetes 38 (9) 41 (14)
NIHSS score,† median (IQR) 2 (0–6) 0
Minor stroke 261 (61)
Moderate stroke 100 (23)
Severe stroke 69 (16)
Stroke type
Ischemic stroke 354 (81)
Primary intracerebral
hemorrhage
39 (9)
Subarachnoid hemorrhage 27 (6)
Unknown stroke 19 (4)
Z1 subsequent events
TIA 10 (2) 57 (19)
Stroke 52 (12) 42 (14)
Coronary events 14 (3) 7 (2)
Peripheral vascular disease
events
3 (1) 1 (o1)
Note. All data expressed as n (%), except where specified. IQR,
interquartile range; MI, myocardial infarction; NIHSS, National
Institutes of Health Stroke Scale; TIA, transient ischemic attack.
* Stroke: 6 missing; TIA: 2 missing.
† Stroke: 9 missing; TIA: 5 missing.
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regression, using robust standard errors, was used to determine
the predictors of 1-year total costs after the index event. Potential
predictors included sex; age; previous history of myocardial
infarction, angina, peripheral vascular disease, hypertension,
atrial fibrillation, diabetes, and disability; premorbid socioeco-
nomic characteristics including age at which patient left educa-
tion, marital status, place of residence, deprivation—as measured
by post code of residence using the index of multiple deprivation,
social class—as coded using the Standard Occupational Classifi-
cation Scheme, and employment status; event type; and event
severity (NIHSS score). Because of observed nonlinear effects on
resource use and costs [14], event severity was included in the
model by using the continuous NIHSS score and its quadratic
term. Age was included as a categorical variable.
Statistical significance was set at P o 0.05. In both multi-
variate analyses, model specification was tested by using Ram-
sey’s reset test and multicollinearity in the predictor variables
was measured from the tolerance value and its inverse, the
variance inflation factor (VIF). The tolerance value is the amount
of variability of a single predictor variable not explained by other
predictor variables, whereas VIF indicates the extent of effects of
other predictor variables on the variance of a selected predictor
variable. Very small tolerance values (o0.1) or high VIF values
(410) indicated high collinearity [15]. For the log-linear regres-
sion, we tested normality of residuals by using Kolmogorov-
Smirnov’s w2 test and by plotting residuals alongside a normal
empirical distribution. To assess the performance of the logistic
regression model in predicting hospitalization after the index
event, we estimated the c statistic, which assesses how the
model correctly predicts a higher probability of hospitalization
in those patients who were hospitalized than the probability for
patients who were not hospitalized. The c statistic was computed
from the area under the receiving operating characteristic curve.Results
Patient Sample
Between April 2003 and March 2007, 379 patients suffered a TIA
and 568 patients suffered a stroke as their first cerebrovascular
event during the OXVASC period. Of these, 84 (22%) patients with
TIA and 129 (23%) patients with stroke were excluded from this
analysis because of a previous history of TIA or stroke. As a
result, 295 patients with TIA and 439 patients with stroke were
included in the analysis.
Of the 439 patients suffering an index stroke, 109 (25%) died
within 1 year following the index event. Eleven (4%) of the 295
patients with TIA died during the year following the index event.
No patient was lost to follow-up during this time. Because of late
presentation or event occurring out of area, there was missing
NIHSS information for nine stroke cases. Of the 430 index strokes
with available NIHSS scores, 261 (61%) were classified as minor,
100 (23%) as moderate, and 69 (16%) as severe. Patients with TIA
and patients with stroke had considerable comorbidities at the
time of their event, with 10% having a history of myocardial
infarction and 50% suffering from hypertension (Table 1).
Of the 439 index strokes, 22 (5%) occurred while the patient
was already in hospital and 8 (3%) of the 295 index TIA also
occurred while the patient was in hospital.
Hospital Resource Use 1 Year Before and After Index TIA or
Stroke
For patients with stroke, a total of 417 hospitalizations were
observed over 439 patient years in the year before the stroke anda total of 720 hospitalizations were observed over 354 patient
years in the year after the stroke. All-cause hospitalizations rose
from 0.95 per patient per follow-up year before the event to 2.04
after the index event (rate ratio 2.14; 95% CI 1.86– 2.47; P o 0.0001;
Table 2). This increase was observed because of significant
increases in hospitalizations with cerebrovascular disease diag-
noses (rate ratio 33.6; 95% CI 19.6–65.7) and nonvascular diag-
noses (rate ratio 1.20; 95% CI 1.03–1.39). The average number of
all-cause days in hospital also increased significantly (32 in the
year after the event vs. 4 in the year before the event; Po 0.0001).
For the purposes of this analysis, reasons for hospitalization were
determined by using primary diagnosis codes. Supplementary
details of the reasons for hospitalization, including secondary
diagnoses, are reported in Appendix 1 in Supplemental Materials
found at http://dx.doi.org/%2010.1016/j.jval.2012.10.013.
Of the 2.04 hospitalizations per patient per follow-up year
occurring after the index stroke, 58% (rate 1.19) were linked to the
index stroke and 8% (rate 0.18) were linked to subsequent
vascular events (Table 3). Most (64%) of the hospitalizations
linked to the index stroke (rate 0.76) and 56% (rate 0.10) of the
hospitalizations linked to subsequent vascular events were coded
by using a cerebrovascular disease diagnosis, but a considerable
minority of hospitalizations linked to the index or subsequent
events were coded by using nonvascular disease diagnoses.
For patients with TIA, a total of 118 hospitalizations were
observed over 295 patient years in the year before the event and a
total of 294 hospitalizations were observed over 289 patient years
in the year after the event. Patients with TIA also had signifi-
cantly higher hospitalization rates in the year after the index
event than in the year before it (1.02 vs. 0.40 per patient per
follow-up year, respectively; Po 0.0001), and spent, on average,
Table 2 – Hospitalizations, days in hospital, and hospitalization costs 1 y before and after index TIA or stroke by ICD-10
diagnosis.
Stroke (n ¼ 439) TIA (n ¼ 295)
Before After Rate ratio/mean
difference (95% CI)
Before After Rate ratio/mean
difference (95% CI)
Number of hospitalizations per patient per follow-up year (rate, SE)
All causes 0.95 (0.05) 2.04 (0.08) 2.14 (1.86 to 2.47) 0.40 (0.04) 1.02 (0.06) 2.54 (2.05 to 3.18)
Cerebrovascular 0.03 (0.01) 0.92 (0.05) 33.6 (19.0 to 65.7) 0 0.26 (0.03) NA
Cardiovascular 0.10 (0.02) 0.13 (0.02) 1.33 (0.86 to 2.05) 0.07 (0.02) 0.11 (0.02) 1.63 (0.91 to 3.01)
Nonvascular 0.82 (0.04) 0.98 (0.05) 1.20 (1.03 to 1.39) 0.33 (0.03) 0.65 (0.05) 1.95 (1.52 to 2.51)
Mean  SD number of days in hospital
All causes 4  13 32  53 28 (23 to 33) 2  13 8  25 6 (3 to 9)
Median (IQR) 0 (0) 6 (0 to 41) 0 (0) 0 (0 to 2)
Cerebrovascular o1  3 20  42 20 (16 to 23) 0  0 3  15 3 (1 to 5)
Cardiovascular 1  4 2  10 1 (1 to 2) o1  1 1  8 1 (0 to 2)
Nonvascular 3  12 11  29 8 (5 to 11) 2  13 4  15 2 (1 to 4)
Mean  SD hospitalization costs (£)
All causes 1,437  4,226 6,629  11,503 5,192 (4,124 to 6,260) 876  3,553 2,410  5,587 1,534 (920 to 2,148)
Median (IQR) 0 (0 to 617) 2,772 (378 to 7,205) 0 (0) 0 (0–2,180)
Cerebrovascular 65  548 3,543  7,636 3,478 (2,767 to 4,189) 0  0 802  2,821 802 (479 to 1,125)
Cardiovascular 331  1,802 455  2,928 124 (188 to 437) 82  651 293  1,873 211 (12 to 433)
Nonvascular 1,041  3,710 2,631  8,125 1,590 (898 to 2,280) 794  3,503 1,315  3,935 521 (68 to 975)
CI, confidence interval; ICD-10, The International Statistical Classification of Diseases and Related Health Problems, 10th Revision; IQR, interquartile
range; NA, not available; TIA, transient ischemic attack.
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pre-event (mean difference 6 days; 95% CI 3–9; P o 0.0001). When
comparing days in hospital in the year before and after the index
TIA, significant increases in hospital bed days were observed for
cerebrovascular (P ¼ 0.0001) and cardiovascular diagnoses (P ¼
0.045) but not for nonvascular diagnoses (P ¼ 0.087; Table 2).
Of the 1.02 hospitalizations per patient per follow-up year
occurring after the index TIA, 25% (rate 0.26) were linked to the
index TIA and 17% (rate 0.17) to subsequent vascular events
(Table 3). A total of 54% (rate 0.14) of the hospitalizations related
to the index TIA and 59% (rate 0.10) of those linked to subsequent
vascular events were coded by using cerebrovascular disease
diagnoses.
Hospital Costs 1 Year Before and After Index TIA or Stroke
For stroke patients, average hospitalization costs increased from
£1437 1 year before the event to £6629 in the year post-event,
representing a significant increase of £5192 (95% CI 4124–6260;
Po 0.0001; Table 2). These cost increases were primarily due to
increased costs in hospitalizations with a cerebrovascular disease
diagnosis, which accounted for 67% (£3478; 95% CI 2767–4189) of
the increase. Significant increases in costs were also observed for
nonvascular hospitalizations (mean difference £1590; 95% CI
898–2,280; Po 0.0001). Of the £6629 costs incurred in the year
after the index stroke, £4224 (64%) were due to hospitalizations
linked to the index stroke and £653 (10%) due to subsequent
vascular events (Table 3). Costs 1 year before and after index
stroke, stratified by stroke type, are reported in Appendix 2 in
Supplemental Materials found at http://dx.doi.org/%2010.1016/j.
jval.2012.10.013.
For patients with TIA, total average costs increased from £876
1 year before the event to £2410 1 year after the index TIA, a
significant increase of £1534 (95% CI 920–2148; Po 0.0001;
Table 2). Fifty-two percent of this observed increase in costs
was due to increases in cerebrovascular hospitalization costs,
which significantly increased by £802 (95% CI 479– 1125;
Po 0.0001) per patient after index TIA. In addition, nonvascularhospitalization costs (mean difference £521; 95% CI 68–975; P ¼
0.025) increased after the index TIA. Patients with TIA incurred
nonsignificantly higher costs because of hospitalizations linked
to subsequent vascular events (£720) than for hospitalizations
linked to the index TIA (£774; P ¼ 0.846; Table 3).
Predictors of 1-Year Costs After Index TIA or Stroke:
Covariate Adjustment
A total of 108 (25%) patients with stroke and 163 (55%) patients
with TIA did not have any hospitalization after the index event,
and therefore incurred no hospitalization costs. To deal with this
distribution of costs, we performed a two-part model to assess
the independent predictors of 1) the patient being hospitalized at
least once (i.e., incurring costs) and 2) conditional on having been
hospitalized, the level of costs incurred.
The independent predictors of whether the patient would
have at least one hospital admission after index TIA or stroke
included previous history of peripheral vascular disease (P ¼
0.018); hospitalization in the year before the index event (P ¼
0.005); and event severity, where a nonlinear association was
observed (Table 4). Increased NIHSS scores were predictive of
being hospitalized at least once following the index event
(P o 0.0001). However, very high NIHSS scores (reflected in the
analysis by the quadratic term) were associated with a lower
probability of being hospitalized (P ¼ 0.003), because of very high
case fatality and patients dying before reaching hospital. Socio-
economic class was also found to be predictive of subsequent
hospitalization in the year following index stroke or TIA, with
skilled nonmanual (P ¼ 0.039) and partly skilled (P ¼ 0.021)
patients less likely to be hospitalized than those classed as
skilled manual.
Conditional on hospital admission, stroke severity as mea-
sured by using the NIHSS score was an independent predictor of
costs. The association between event severity and costs, however,
was nonlinear, due to the greatly increased case fatality, and
corresponding reductions in length of stay, observed at high
NIHSS scores (Table 4). Those patients who incurred higher
Table 3 – Hospitalizations, days in hospital, and hospitalization costs due to index and subsequent events by ICD-10
diagnosis.
Hospitalizations per patient
per year (SE)
Mean  SD days in
hospital
Mean  SD hospitalization
costs (£)
Stroke patients (n ¼ 439)
Within 7 d of index stroke
Any coding 1.19 (0.06) 23  44 4,224  9,405
Hospitalizations coded as
cerebrovascular
0.76 (0.05) 17  39 3,036  7,151
Hospitalizations coded as
cardiovascular
0.06 (0.01) 1  5 185  1,317
Hospitalizations coded as
nonvascular
0.37 (0.03) 5  19 1,002  5,901
Within 7 d of subsequent vascular
events
Any coding 0.18 (0.02) 2 16) 653  4,126
Hospitalizations coded as
cerebrovascular
0.10 (0.02) 1  9 308  1,993
Hospitalizations coded as
cardiovascular
0.04 (0.01) 1  8 187  2,506
Hospitalizations coded as
nonvascular
0.04 (0.01) 1  8 158  2,259
TIA patients (n ¼ 295)
Within 7 d of index TIA
Any coding 0.26 (0.03) 3  16 774  3,525
Hospitalizations coded as
cerebrovascular
0.14 (0.02) 1  11 329  1,938
Hospitalizations coded as
cardiovascular
0.02 (0.01) o1  4 95  1,022
Hospitalizations coded as
nonvascular
0.09 (0.02) 1  11 350  2,797
Within 7 d of subsequent vascular
events
Any coding 0.17 (0.02) 2  16 720  3,252
Hospitalizations coded as
cerebrovascular
0.10 (0.02) 1  9 430  1,968
Hospitalizations coded as
cardiovascular
0.02 (0.01) o1  2 53  588
Hospitalizations coded as
nonvascular
0.05 (0.01) 1  8 236  1,751
ICD-10, The International Statistical Classification of Diseases and Related Health Problems, 10th Revision; SE, standard error; TIA, transient ischemic
attack.
* Including associated hospital transfers.
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higher costs post-event (P ¼ 0.001). Patients with a history of
atrial fibrillation before index stroke or TIA were also found to
incur significantly higher costs post-event (P ¼ 0.036).
For both regression models, we found that no predictor
variable had a tolerance level below 0.1 and no VIF value higher
than 10, which indicated no problems with collinearity.Discussion
In line with other costing studies evaluating costs before and
after stroke [1–4], our results showed increased hospitalization
rates, days in hospital, and total costs after stroke. Despite the
high costs observed during the first 12 months after the index
stroke (£6629 on average), the costs incurred by these patients
over the 1 year before their event were also considerable (£1437
on average). Our study, however, is the first to show that both
hospital resource use and costs, as with stroke, increasedconsiderably after TIA, from £876 in the year before TIA onset
to £2410 in the year after.
Our study also improved on previous work by analyzing
reasons for hospital use and costs. More than 67% of the
increased levels of hospitalization costs observed in the year
after the index stroke were due to significant increases in
hospitalizations with a cerebrovascular event diagnosis. Such
increases were primarily due to hospitalizations linked to the
index stroke, with only a small minority of hospitalizations
linked to subsequent vascular events. For TIA, most of the
hospitalizations occurring in the year after index TIA were due
to nonvascular causes, with only 25% of the hospitalizations
occurring within 7 days of the index TIA and a further 17% due to
subsequent vascular events.
Our study showed that for patients with TIA and patients with
stroke, when compared with the 12 months before the index
event, costs for hospitalizations with nonvascular diagnoses
increased significantly after event onset (from £1041 to £2631 in
patients with stroke and from £794 to £1315 in patients with TIA).
For patients with stroke, the increased costs were driven mainly
Table 4 – Independent predictors of 1-y hospitalization and costs after TIA and stroke.
Hospital admission after event If hospitalized, 1-y costs (log transformed)
Odds ratio P 4 9z9 Coefficient P 4 9z9
Hospitalized before event 1.47 0.005 NA NA
Costs before event NA NA o0.01 0.001
Gender
Female Reference case Reference case
Male 1.23 0.361 0.15 0.222
Age (y)
o65 0.76 0.444 0.18 0.379
65–74 0.65 0.105 0.34 0.038
Z75 Reference case Reference case
Previous history of
Peripheral vascular disease 3.28 0.018 0.32 0.126
Myocardial infarction 1.05 0.904 o0.01 0.991
Angina 1.05 0.894 0.45 0.014
Hypertension 1.05 0.797 0.05 0.691
Atrial fibrillation 1.32 0.361 0.30 0.036
Disability 1.55 0.242 0.09 0.563
Event type
TIA Reference case Reference case
Stroke 1.51 0.068 0.24 0.102
NIHSS score 1.50 o0.001 0.11 0.001
NIHSS score ^ 2 0.99 0.003 0.01 0.037
Premorbid place of residence
Own home Reference case Reference case
Home friend/family 0.66 0.621 0.46 0.395
Warden accommodation 3.03 0.110 0.27 0.313
Care home 0.66 0.625 0.69 0.067
Lived alone before event 1.00 0.989 0.08 0.715
Premorbid marital status
Married Reference case Reference case
Widowed 1.18 0.655 0.13 0.593
Single 0.65 0.355 0.44 0.105
Separated 1.28 0.588 0.18 0.552
Living with partner 0.81 0.747 0.19 0.504
Premorbid employment status
Full-time 1.05 0.897 0.18 0.483
Part-time 1.23 0.570 0.31 0.226
Caring for home 1.32 0.667 0.53 0.139
Unemployed 0.68 0.667 0.32 0.381
Unable to work 3.99 0.120 0.20 0.612
Retired Reference case Reference case
Socioeconomic status
Professional 0.62 0.269 0.01 0.967
Managerial 0.83 0.537 0.09 0.577
Skilled nonmanual 0.51 0.039 0.24 0.239
Skilled manual Reference case Reference case
Partly skilled 0.44 0.021 0.24 0.282
Nonskilled 0.88 0.741 0.13 0.502
Age left education 0.97 0.397 0.03 0.103
Index of multiple deprivation 1.01 0.378 0.01 0.681
Constant 0.99 0.992 8.61 o0.001
No. 633 No. 405
P4 w2 o0.001 P4 F o0.001
Adjusted R2 0.126 Adjusted R2 0.175
c Statistic 0.790 RMSE 1.102
Reset test 0.311
Reset test 0.367 Kolmogorov-Smirnov 0.579
NA, not applicable; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischemic attack.
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VA L U E I N H E A LT H 1 6 ( 2 0 1 3 ) 2 8 0 – 2 8 7286by significant increases in hospitalizations with ICD-10 Chapter 11
(Diseases of the Digestive System), Chapter 14 (Diseases of the
Genitourinary System), and Chapter 18 (Symptoms, Signs and
Abnormal Clinical Findings) diagnoses, whereas for patients with
TIA, the increases were driven mainly by rises in hospitalizations
with Chapter 10 (Diseases of the Respiratory System), Chapter 18
(Symptoms, Signs and Abnormal Clinical Findings), and Chap-
ter 21 (External Causes of Morbidity and Mortality) diagnoses.
Previous studies have shown that hospital coding is subject to
error [16–18]. We found that 31% of the hospitalizations linked to
the index stroke were not given a primary diagnosis of cerebro-
vascular disease (with only 11% of these hospitalizations having a
secondary diagnosis of cerebrovascular disease). While a number
of these may genuinely have been entirely unrelated, it seems
highly likely that most use was in fact related to the index event.
Therefore, our findings that nonvascular hospitalization resource
use and costs increased after the index event could be partly
explained by TIA and stroke not being coded appropriately in HES
records. The findings from our study, therefore, caution against
including only those costs directly associated or attributable to a
disease or intervention in a costing study or an economic
evaluation. In our case, if only those hospitalizations with a
primary diagnosis of cerebrovascular disease were to have been
considered in this study, the impact of TIA or stroke on subse-
quent costs would have been severely underestimated.
Our study was based on an unselected patient sample,
including all relevant patients regardless of whether they were
initially treated in the community or in hospital. We believe that
our cost results will provide useful information to help plan
service provision and resource allocation. Our cost results will
also be of use to other researchers as an input to decision-
analytic models, which are becoming increasingly popular to
assess the cost-effectiveness of specific intervention to prevent
or treat stroke. Our overall costs are, of course, applicable only to
the United Kingdom and possibly to similar health care systems
in which a high proportion of patients with minor stroke and TIA
are investigated and treated in the outpatient setting. However,
our predictors of cost are more likely to be generalizable to other
health care settings.
However, our study had a number of limitations. First, although
HES records also contain information on outpatient and emergency
care contacts, such information does not include any diagnosis. We
also did not include resource use and costs associated with primary
care and social care (including long-term institutionalization into a
care home), the latter accounting for a high proportion of post-
stroke costs [9]. As better primary and outpatient care have been
shown to reduce the risk of both incident and recurrent stroke
[19,20], data on these costs might have revealed associations
between primary/outpatient care and inpatient care costs. Second,
we did not include 267 patients recruited during the first year of
OXVASC as we did not obtain HES records for the year before their
index event. This reduced the study sample and the power required
to perform statistical analyses.
As stroke and TIA are associated with old age and often occur in
patients with other comorbidities [8], such patients are therefore
likely to consume substantial health care resources even if they had
not had a cerebrovascular event. In this study, we assessed the
costs that could be directly attributable to stroke and TIA by
comparing costs 1 year before and after the index event. As with
any before and after study, there is the possibility that unobserved
external factors could have biased our results. Another way to
assess the costs that could be directly attributable to stroke or TIA,
and limit the potential for such bias, would have been a case-
control study in which the costs incurred by patients with stroke or
TIA were compared with those incurred by gender- and age-
matched controls. Fourth, the low hospitalization rates following
subsequent vascular events after index TIA or stroke were in partobserved because the patient was already hospitalized because of
the index event. So, for example, 46% of subsequent strokes
occurred while the patient was already hospitalized for the index
event. As it was not possible to separately attribute resources to the
multiple events, all resource use and costs were combined together
as part of the initial event. Finally, as HRG costs are particularly
susceptible to primary diagnosis codes, a wrong primary diagnosis
code would alter the cost attached to a particular hospitalization.
In conclusion, hospital costs increased considerably after
index stroke or TIA, primarily because of increased cerebrovas-
cular hospitalizations. The finding that hospitalizations and costs
for nonvascular conditions also increased after the index event
could in part be explained by the miscoding of TIA- or stroke-
related hospitalizations in electronic information systems.
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